About this resource:
Source: The Cochrane Collaborative
Last Reviewed: February 2021
Workgroups: Mental Health and Mental Disorders Workgroup
In this Cochrane systematic review, researchers studied the effectiveness and safety of antidepressant drugs in comparison with other treatments (psychological, psychosocial, or pharmacological), placebo, or treatment as usual for postnatal (postpartum) depression.
Researchers found limited evidence regarding the effectiveness and safety of antidepressants to manage postpartum depression, particularly for people with more severe depression. They found low‐certainty evidence that SSRI antidepressants may be more effective in treating postpartum depression than placebo, as measured by response and remission rates.
However, further research is needed to better understand whether, and for whom, antidepressants or other treatments are more effective at treating postpartum depression, and whether some antidepressants are more effective or better tolerated than others. Future randomized controlled trials should focus on larger samples, longer follow‐up, comparisons with alternative treatment modalities, and inclusion of child and parenting outcomes.
Objectives related to this resource (2)
Suggested Citation
Brown JV, Wilson CA, Ayre K, et al. (2021). Antidepressant treatment for postnatal depression. Retrieved from https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013560.pub2/full.